Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;25(2):136-47.
doi: 10.3802/jgo.2014.25.2.136. Epub 2014 Apr 9.

Adjuvant therapy for endometrial cancer

Maria C Deleon  1 , Natraj R Ammakkanavar  2 , Daniela Matei  3
Affiliations
Review

Adjuvant therapy for endometrial cancer

Maria C Deleon et al. J Gynecol Oncol. 2014 Apr.

Abstract

Endometrial cancer is a common gynecologic malignancy typically diagnosed at early stage and cured with surgery alone. Adjuvant therapy is tailored according to the risk of recurrence, estimated based on the International Federation of Gynecology and Obstetrics (FIGO) stage and other histological factors. The objective of this manuscript is to review the evidence guiding adjuvant therapy for early stage and locally advanced uterine cancer. For patients with early stage disease, minimizing toxicity, while preserving outstanding cure rates remains the major goal. For patients with locally advanced endometrial cancer optimal combined regimens are being defined. Risk stratification based on molecular traits is under development and may aid refine the current risk prediction model and permit personalized approaches for women with endometrial cancer.

Keywords: Adjuvant therapy; Early stage; Endometrial cancer; Locally advanced; Risk stratification.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. International Agency for Research on Cancer. GLOBALCAN 2008: cancer incidence and mortality worldwide. Lyon, France: IARC Press; 2010.
    1. American Cancer Society. Cancer facts & figures 2012. Atlanta, GA: American Cancer Society; 2012.
    1. Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 2009;16:8–13. - PubMed
    1. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10–17. - PubMed
    1. Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol. 2011;54:215–218. - PubMed